The stock of Mettrum Health Corp (CVE:MT) is a huge mover today! About 355,253 shares traded hands. Mettrum Health Corp (CVE:MT) has risen 6.00% since October 10, 2016 and is uptrending. It has outperformed by 1.22% the S&P500.
The move comes after 8 months negative chart setup for the $197.21 million company. It was reported on Nov, 9 by Barchart.com. We have $3.60 PT which if reached, will make CVE:MT worth $23.67 million less.
More notable recent Mettrum Health Corp (CVE:MT) news were published by: Investingnews.com which released: “Mettrum Health” on June 06, 2016, also Reuters.com with their article: “BRIEF-Mettrum Health Corp says all licenses at Bowmanville facilities rene…” published on November 02, 2016, Reuters.com published: “BRIEF-Mettrum Health Q1 loss per share $0.03” on November 16, 2014. More interesting news about Mettrum Health Corp (CVE:MT) were released by: Marketwired.com and their article: “Mettrum Health Corp. Announces Full Exercise of Over-Allotment Option” published on September 07, 2016 as well as Marketwired.com‘s news article titled: “Mettrum Health Corp. Responds to Health Canada’s Proposed Access to Cannabis …” with publication date: August 11, 2016.
Mettrum Health Corp. is a producer of medical cannabis. The company has a market cap of $197.21 million. The Firm is also a licensed producer and distributer of industrial cannabis (hemp) products, including Mettrum’s functional food line, Mettrum Originals. It currently has negative earnings. It has a production capacity of over 12,000 kilograms of medical cannabis per year.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.